A new study based on the genetic information from 150,000 people has discovered a rare gene mutation that prevents even obese people from developing type 2 diabetes.
Synthesizing the mutation with drugs would be particularly promising for people with HIV because we have elevated rates of diabetes.
Are Monthly PrEP Injections (Rather Than Once-a-Day Pills) In HIV Prevention’s Near Future?
CDC Scientists have found that the long-acting investigational ARV GSK744 can fully prevent SIV transmission in female pigtail macaques. But how long will it be until we can test on the human form?
The conventional male condom leaves a lot to be desired: Latex allergies, lost erections and the many men who outright refuse to use them. Sometimes they break, and their design has been unchanged for nearly a century.
Public health experts, scientists and manufacturers are focused on building better condoms, both male and female—and even one specifically for anal sex. But most of the new condoms in the pipeline probably won’t become available in the United States for several years, if ever. What gives?
Do you know the history of condoms?
New Programs for Positive Women in NYC! Health People in the Bronx has launched 2 new, forward-thinking initiatives to help with its community education efforts:
1) The organization will now focus on treating women for trauma and abuse as part of their HIV prevention and care, and
2) It will use a big social media campaign to reach women with effective HIV prevention and care messages.
For more info, click here.
PEPFAR Gives $20M to Support Non-ARV Microbicides
A gel-like product that does not contain antiretrovirals could eliminate the need for HIV screening needed for ARV microbicides, as well as reduce drug-resistant HIV strains. Even better, it could lead to an over-the-counter HIV prevention product.
"If an extrinsic motivator such as money is used, not providing enough may increase transmission, not reduce it….What if the person is only paid $50 bucks and given a bottle of pills? Would this person use this money to buy more crystal meth leading to further non-compliance and further transmission?"
Paying People To End AIDS
P4P4P, aka: “pay for performance for patients,” provides financial or other reward for patients to get tested, engage care, stay in care, and achieve viral suppression. It is not included in HIV guidelines or even polite discussions, even though it is low-cost and virtually always works.
Housing Works and nearly 1000 members of New York’s HIV/AIDS community, are marking the 25th commemoration of World AIDS Day by declaring that now is the time to end AIDS as an epidemic here in New York State.
Join us on World AIDS Day, Sunday, December 1st at 2:00 PM in Times Square between 45th and 46th Streets on 7th Avenue.
Latinos represent about 16 percent of the U.S. population, but they account for about 21 percent of all new HIV cases across the country. There’s also the continuing occurrence among Latinos of “late testing”—developing AIDS within 12 months of an HIV diagnosis. And then there’s the fact that HIV rates among Latino gay and bisexual men are increasing at an alarming pace. These combined factors lead to a sobering question: Are Latinos the next wave of the epidemic?